You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

N-003

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pharmacokinetics in Healthy Adults Trial in London (BPL-003, Placebo)

Recruiting
  • Pharmacokinetics in Healthy Adults
  • London, United Kingdom
    Hammersmith Medicines Research
Apr 21, 2022

Cirrhosis, Portal Hypertension, Ascites Trial in Barcelona, Majadahonda, Madrid (Ambrisentan)

Terminated
  • Cirrhosis
  • +2 more
  • Barcelona, Catalunya, Spain
  • +5 more
Feb 23, 2021

Rett Syndrome Trial in Australia, Canada, United Kingdom (ANAVEX2-73 oral liquid, Placebo oral liquid)

Recruiting
  • Rett Syndrome
  • ANAVEX2-73 oral liquid
  • Placebo oral liquid
  • Sydney, New South Wales, Australia
  • +11 more
Jan 31, 2023

Mycobacterium Infections, Nontuberculous Trial in Worldwide (ALIS, Azithromycin, Ethambutol)

Recruiting
  • Mycobacterium Infections, Nontuberculous
  • Birmingham, Alabama
  • +172 more
Jan 23, 2023

Pulmonary Arterial Hypertension Trial in Worldwide (Treprostinil Palmitil, Placebo)

Recruiting
  • Pulmonary Arterial Hypertension
  • Treprostinil Palmitil
  • Placebo
  • West Hollywood, California
  • +43 more
Jul 21, 2022

Mycobacterium Infections, Nontuberculous Trial in Worldwide (ALIS, Azithromycin, Ethambutol)

Active, not recruiting
  • Mycobacterium Infections, Nontuberculous
  • Birmingham, Alabama
  • +110 more
Jan 23, 2023

Prurigo Nodularis Trial in Worldwide (INCB054707, Placebo)

Recruiting
  • Prurigo Nodularis
  • Phoenix, Arizona
  • +48 more
Dec 1, 2022

Covid19 Trial in Brazil, United States (Remdesivir, Remdesivir Placebo, Aviptadil)

Completed
  • Covid19
  • Remdesivir
  • +4 more
  • Tucson, Arizona
  • +39 more
Dec 16, 2022

Covid19, Hypoxemia Trial in Spain (Ambrisentan, Placebo)

Recruiting
  • Covid19
  • Hypoxemia
  • Gijón, Asturias, Spain
  • +10 more
Aug 4, 2021

COVID-19 Trial in Worldwide (LY3819253, Placebo, Remdesivir)

Completed
  • COVID-19
  • LY3819253
  • +2 more
  • Tucson, Arizona
  • +56 more
Mar 22, 2023

COVID-19 Trial in Worldwide (BRII-196, BRII-198, Placebo)

Completed
  • COVID-19
  • BRII-196
  • +3 more
  • Tucson, Arizona
  • +106 more
Mar 24, 2023

COVID-19 Trial in Worldwide (VIR-7831, Placebo, Remdesivir)

Completed
  • COVID-19
  • VIR-7831
  • +2 more
  • Tucson, Arizona
  • +104 more
Mar 22, 2023

COVID-19 Trial in Worldwide (AZD7442, Placebo, Remdesivir)

Active, not recruiting
  • COVID-19
  • AZD7442
  • +2 more
  • Tucson, Arizona
  • +123 more
Mar 24, 2023

Wiskott-Aldrich Syndrome Trial in Paris, London (Autologous CD34+ cells transduced with WASP lentiviral vector)

Active, not recruiting
  • Wiskott-Aldrich Syndrome
  • Autologous CD34+ cells transduced with WASP lentiviral vector
  • Paris, France
  • +1 more
May 31, 2021

COVID-19 Trial in Worldwide (MP0420, Placebo, Remdesivir)

Active, not recruiting
  • COVID-19
  • Tucson, Arizona
  • +104 more
Mar 22, 2023

Hematologic Malignancies Trial in Worldwide (Nemtabrutinib)

Recruiting
  • Hematologic Malignancies
  • Torrance, California
  • +51 more
Jan 12, 2023

NonSegmental Vitiligo Trial in Canada, United States (INCB054707, Placebo)

Active, not recruiting
  • NonSegmental Vitiligo
  • Hoover, Alabama
  • +30 more
Nov 14, 2022

Locally Advanced Cervical Cancer Trial in Worldwide (Volrustomig, Placebo)

Recruiting
  • Locally Advanced Cervical Cancer
  • Volrustomig
  • Placebo
  • Savannah, Georgia
  • +85 more
Oct 6, 2023

HNSCC Trial in Worldwide (Eftilagimod alpha, Pembrolizumab)

Recruiting
  • HNSCC
  • Birmingham, Alabama
  • +28 more
Nov 29, 2022

Hyperkalaemia, Heart Failure With Reduced Ejection Fraction Trial in Worldwide (Sodium zirconium cyclosilicate, Placebo,

Recruiting
  • Hyperkalaemia
  • Heart Failure With Reduced Ejection Fraction
  • Sodium zirconium cyclosilicate
  • +2 more
  • Fairhope, Alabama
  • +126 more
Jan 20, 2023

Cutaneous Lupus Erythematosus Trial in Worldwide (SAR443122, Placebo)

Recruiting
  • Cutaneous Lupus Erythematosus
  • Thousand Oaks, California
  • +54 more
Aug 1, 2022

Carcinoma Trial in Worldwide (osimertinib, savolitinib, )

Recruiting
  • Carcinoma
  • La Jolla, California
  • +95 more
Feb 1, 2023

Healthy, Safety and Tolerability Trial in Cypress (DF-003, Placebo)

Recruiting
  • Healthy
  • Safety and Tolerability
  • Cypress, California
    Altasciences Clinical Los Angeles, Inc
Aug 9, 2023

Cervical Cancer Trial in Worldwide (Tiragolumab, Atezolizumab)

Active, not recruiting
  • Cervical Cancer
  • Phoenix, Arizona
  • +65 more
Jan 19, 2023

Malignant Melanoma Trial in Worldwide (Pembrolizumab, Lenvatinib, Placebo for lenvatinib)

Active, not recruiting
  • Malignant Melanoma
  • Pembrolizumab
  • +2 more
  • Los Angeles, California
  • +118 more
Aug 22, 2022